tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMRX Stock Latest News

Immuneering updated 12-month data for atebimetinib ‘encouraging,’ says Leerink
The FlyImmuneering updated 12-month data for atebimetinib ‘encouraging,’ says Leerink
1d ago
IMRX
RVMD
Midday Fly By: Defense stocks surge on Trump budget request
PremiumThe Fly
Midday Fly By: Defense stocks surge on Trump budget request
1d ago
F
AA
Immuneering: Phase 2a Strength of Atebimetinib in First-Line Pancreatic Cancer Supports Buy Rating Despite Competitive Overhang
PremiumRatings
Immuneering: Phase 2a Strength of Atebimetinib in First-Line Pancreatic Cancer Supports Buy Rating Despite Competitive Overhang
2d ago
IMRX
Closing Bell Movers: Defense stocks surge on Trump military budget comments
PremiumThe Fly
Closing Bell Movers: Defense stocks surge on Trump military budget comments
2d ago
FC
GD
Immuneering reports ‘positive’ survival, safety data from atebimetinib trial
PremiumThe Fly
Immuneering reports ‘positive’ survival, safety data from atebimetinib trial
2d ago
IMRX
Immuneering Reports Strong Phase 2a Pancreatic Cancer Survival Data
PremiumCompany AnnouncementsImmuneering Reports Strong Phase 2a Pancreatic Cancer Survival Data
2d ago
8K
IMRX
Immuneering management to meet with Oppenheimer
Premium
The Fly
Immuneering management to meet with Oppenheimer
2d ago
IMRX
Immuneering to announce OS data from Phase 2a trial of atebimetinib, mGnP
Premium
The Fly
Immuneering to announce OS data from Phase 2a trial of atebimetinib, mGnP
17d ago
IMRX
Immuneering on track to dose first patient in pancreatic cancer trial in 2026
PremiumThe Fly
Immuneering on track to dose first patient in pancreatic cancer trial in 2026
23d ago
IMRX
Immuneering to be added to the Nasdaq Biotechnology Index
PremiumThe Fly
Immuneering to be added to the Nasdaq Biotechnology Index
24d ago
IMRX
Immuneering Corp. Shines in Positive Earnings Call
PremiumCompany Announcements
Immuneering Corp. Shines in Positive Earnings Call
2M ago
IMRX
Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating
PremiumRatings
Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating
2M ago
IMRX
Immuneering Corp. Reports Strong Q3 2025 Progress
PremiumCompany AnnouncementsImmuneering Corp. Reports Strong Q3 2025 Progress
2M ago
IMRX
Immuneering reports Q3 EPS (38c), consensus (39c)
Premium
The Fly
Immuneering reports Q3 EPS (38c), consensus (39c)
2M ago
IMRX
Immuneering expects cash to fund operations into 2029
Premium
The Fly
Immuneering expects cash to fund operations into 2029
2M ago
IMRX
IMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
IMRX
3 Best Stocks to Buy Now, 11/3/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 11/3/2025, According to Top Analysts
2M ago
CORZ
IMRX
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
2M ago
U
APP
Immuneering initiated with an Outperform at Leerink
PremiumThe Fly
Immuneering initiated with an Outperform at Leerink
2M ago
IMRX
Immuneering price target raised to $12 from $10 at Mizuho
PremiumThe FlyImmuneering price target raised to $12 from $10 at Mizuho
2M ago
IMRX
Two new option listings and three option delistings on October 2nd
Premium
The Fly
Two new option listings and three option delistings on October 2nd
3M ago
BBBY
COOP
Immuneering’s Promising Phase 2a Data and Safety Profile Drive Buy Rating
Premium
Ratings
Immuneering’s Promising Phase 2a Data and Safety Profile Drive Buy Rating
3M ago
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >